3/5
02:04 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/1
05:58 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) was upgraded by analysts at Alliance Global Partners to a "strong-buy" rating.
High
Report
Aptose Biosciences Inc. (NASDAQ: APTO) was upgraded by analysts at Alliance Global Partners to a "strong-buy" rating.
2/25
02:07 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/20
07:32 am
apto
Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort
High
Report
Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort
2/18
05:28 pm
apto
Aptose Announces Reverse Share Split [Canadian Business Journal (Canada)]
Medium
Report
Aptose Announces Reverse Share Split [Canadian Business Journal (Canada)]
2/18
04:47 pm
apto
Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance [Seeking Alpha]
Medium
Report
Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance [Seeking Alpha]
2/18
04:30 pm
apto
Aptose Announces Reverse Share Split
High
Report
Aptose Announces Reverse Share Split
2/17
01:30 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/13
06:07 pm
apto
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility [Yahoo! Finance]
Low
Report
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility [Yahoo! Finance]
2/13
05:28 pm
apto
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility [Canadian Business Journal (Canada)]
Medium
Report
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility [Canadian Business Journal (Canada)]
2/13
04:30 pm
apto
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
High
Report
Aptose Enters into $25 Million Committed Equity Facility and Establishes New At-The-Market Facility
2/12
11:58 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Low
Report
Aptose Biosciences Inc. (NASDAQ: APTO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
2/12
07:00 am
apto
Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial
Low
Report
Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial
2/9
01:34 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/1
02:06 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/24
02:01 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/16
02:09 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/10
08:03 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
Medium
Report
Aptose Biosciences Inc. (NASDAQ: APTO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
1/9
05:28 pm
apto
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial [Canadian Business Journal (Canada)]
Low
Report
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial [Canadian Business Journal (Canada)]
1/9
04:00 pm
apto
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
Low
Report
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
1/8
02:01 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
12/31
02:44 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
12/23
02:07 am
apto
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptose Biosciences Inc. (NASDAQ: APTO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
12/19
05:28 pm
apto
Aptose Announces Positive Decision by Nasdaq Hearings Panel [Canadian Business Journal (Canada)]
High
Report
Aptose Announces Positive Decision by Nasdaq Hearings Panel [Canadian Business Journal (Canada)]
12/19
04:17 pm
apto
Aptose Announces Positive Decision by Nasdaq Hearings Panel [Yahoo! Finance]
High
Report
Aptose Announces Positive Decision by Nasdaq Hearings Panel [Yahoo! Finance]